Bicara Therapeutics (BCAX) Tax Rate (2023 - 2026)

Bicara Therapeutics (BCAX) has 4 years of Tax Rate data on file, last reported at 0.09% in Q1 2026.

• For the quarter ending Q1 2026, Tax Rate rose 10.0% year-over-year to 0.09%; the trailing twelve-month figure through Mar 2026 stood at 0.13% (up 15.0% YoY), and the FY2025 full-year result was 0.16%, up 12.0% from the prior year.
• Tax Rate for Q1 2026 stood at 0.09%, up from 0.14% in the prior quarter.
• Across five years, Tax Rate topped out at 0.01% in Q1 2024 and bottomed at 0.9% in Q4 2024.
• The 4-year median for Tax Rate is 0.13% (2025), against an average of 0.21%.
• The widest annual swing landed in 2024, when Tax Rate tumbled 86 bps; it then jumped 75 bps in 2025.
• A 4-year view of Tax Rate shows it stood at 0.04% in 2023, then slumped by 2127 bps to 0.9% in 2024, then jumped by 84 bps to 0.14% in 2025, then soared by 35 bps to 0.09% in 2026.
• The last three Tax Rate figures came in at 0.09% (Q1 2026), 0.14% (Q4 2025), and 0.11% (Q3 2025), per Business Quant data.

Peer Comparison